Search - Prime Therapeutics
Navigate to
-
Forbes
PA Sub-Categories: GLP-1 Prime Article: In the News -
Publications Clinical Highlights: November 2024 Your monthly source for drug information highlights. November 27, 2024 Weight Management Corner: catch up on recent publications and study findings...
-
Prime Therapeutics Report shares more about single-treatment gene therapies and proper management
PA Sub-Categories: Specialty drugs Prime Article: Stories -
Gene therapy harnesses the body’s capacity to heal itself
Prime Article: Perspectives -
Cover image for The evolution of GLP-1s Developing a holistic, individualized strategy to capitalize on opportunities and outcomes Prime Therapeutics /the-evolution-of-glp-1s About Prime...
Prime Article: Research & Publications PA Research & Publications: White Papers -
publications Metabolic dysfunction–associated steatohepatitis (MASH) A new era in liver health: Treatment innovation, payer strategy, and pipeline momentum August 15, 2025 Prime Therapeutics’...
-
New report explores traditional, specialty therapy trend impact to employers
PA Sub-Categories: Specialty drugs Prime Article: Stories -
From next-gen CFTR modulators to gene therapy and real-world drug impact, cystic fibrosis care is constantly evolving. Maryam Tabatabai, PharmD, of Prime Therapeutics, explains how innovative...
PA Sub-Categories: Specialty drugs Prime Article: Stories -
Publications Clinical Highlights: February 2025 Your monthly source for drug information highlights. February 28, 2025 Trending topics The annual report Cancer statistics, 2025 from the American...
-
cover image for Summer 2025 Issue: Clinical Insights – MASH A new era in liver health: Treatment innovation, payer strategy, and pipeline momentum Prime Therapeutics...
Prime Article: Research & Publications PA Research & Publications: Clinical Insights White Papers